LF
Laurent Fischer
CEO, President and Director

Laurent Fischer insider trades: Adverum Biotechnologies (ADVM) stock buys and sales

CEO, President and Director, Adverum Biotechnologies Last trade Dec 8, 2025 52 Form 4 filings
$0
Sold, last 12 months
0 sales
$554K
Bought, last 12 months
1 buy
11
Open-market trades
since 2019
7
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Laurent reports to the SEC

and 1 more company

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 8, 2025ADVM↑ Buy$554K
May 15, 2025ADVM↓ Sell$18K
Mar 15, 2023ADVM↓ Sell$32K
Sep 19, 2022ADVM↓ Sell$44K
Apr 20, 2022ADVM↑ Buy$28K
Dec 9, 2021ADVM↑ Buy$46K
Mar 24, 2021ADVM↑ Buy$99K
Jan 15, 2021ADVM↑ Buy$99K
Aug 17, 2020ADVM↑ Buy$100K
Sep 17, 2019MIRM↑ Buy$20K
Sep 10, 2019MIRM↑ Buy$49K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ADVM insiders

Open-market trades in the last 12 months

About Laurent Fischer's insider trades

Laurent Fischer is CEO, President and Director at Adverum Biotechnologies (ADVM). Since Sep 10, 2019, Laurent has reported 8 open-market purchases worth $994K and 3 sales worth $94K on SEC Form 4. In the last 12 months: 1 buy ($554K).

Their filings also include grants and awards (37 filings), shares returned to the company (5 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADVM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.